Radiation Dose-Volume Effects of the Urinary Bladder

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 3 SUPPL., 2010, Pages

  Viswanathan, Akila N ^a   Yorke, Ellen D ^b   Marks, Lawrence B ^c   Eifel, Patricia J ^d   Shipley, William U ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIATION DOSE; RADIATION TOLERANCES; URINARY BLADDER;

IRRADIATION;

RADIATION EFFECTS;

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE;

ARTICLE; BIOLOGICAL MODEL; BLADDER; BLADDER CANCER; BLADDER INJURY; COMORBIDITY; GYNECOLOGIC CANCER; GYNECOLOGIC SURGERY; HEMORRHAGIC CYSTITIS; HUMAN; INCONTINENCE; IRRADIATION; MATHEMATICAL MODEL; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION RESPONSE; RISK FACTOR; UROLOGIC SURGERY; UTERINE CERVIX CANCER; VESICOURETERAL REFLUX;

FEMALE; FORECASTING; HUMANS; HYSTERECTOMY; MALE; MODELS, BIOLOGICAL; MOVEMENT; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UTERINE CERVICAL NEOPLASMS;

EID: 76449105485     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.090     Document Type: Article

References (57)

1. Marks L.B., Carroll P.R., Dugan T.C., et al. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 31 (1995) 1257-1280
2. Eifel P.J., Levenback C., Wharton J.T., et al. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 32 (1995) 1289-1300
3. Gardner B.G., Zietman A.L., Shipley W.U., et al. Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer. J Urol 167 (2002) 123-126
4. Talcott J.A., Rieker P., Clark J.A., et al. Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study. J Clin Oncol 16 (1998) 275-283
5. Xiong L., Viswanathan A., Stewart A.J., et al. Deformable structure registration of bladder through surface mapping. Med Phys 33 (2006) 1848-1856
6. Hellebust T.P., Dale E., Skjonsberg A., et al. Interfraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations. Radiother Oncol 60 (2001) 273-280
7. Muren L.P., Smaaland R., and Dahl O. Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiother Oncol 69 (2003) 291-304
8. Turner S.L., Swindell R., Bowl N., et al. Bladder movement during radiation therapy for bladder cancer: Implications for treatment planning. Int J Radiat Oncol Biol Phys 39 (1997) 355-360
9. Duncan W., and Quilty P.M. The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 7 (1986) 299-310
10. Moonen L., van der Voet H., Horenblas S., et al. A feasibility study of accelerated fractionation in radiotherapy of carcinoma of the urinary bladder. Int J Radiat Oncol Biol Phys 37 (1997) 537-542
11. Rodel C., Grabenbauer G.G., Kuhn R., et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results. J Clin Oncol 20 (2002) 3061-3071
12. Scholten A.N., Leer J.W., Collins C.D., et al. Hypofractionated radiotherapy for invasive bladder cancer. Radiother Oncol 43 (1997) 163-169
13. Mameghan H., Fisher R.J., Watt W.H., et al. The management of invasive transitional cell carcinoma of the bladder: Results of definitive and preoperative radiation therapy in 390 patients treated at the Prince of Wales Hospital, Sydney, Australia. Cancer 69 (1992) 2771-2778
14. Perdona S., Autorino R., Damiano R., et al. Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer: A multi-institutional, long-term experience. Cancer 112 (2008) 75-83
15. Mangar S.A., Foo K., Norman A., et al. Evaluating the effect of reducing the high-dose volume on the toxicity of radiotherapy in the treatment of bladder cancer. Clin Oncol (R Coll Radiol) 18 (2006) 466-473
16. Cowan R.A., McBain C.A., Ryder W.D., et al. Radiotherapy for muscle-invasive carcinoma of the bladder: Results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy. Int J Radiat Oncol Biol Phys 59 (2004) 197-207
17. Yavuz A.A., Yavuz M.N., Ozgur G.K., et al. Accelerated superfractionated radiotherapy with concomitant boost for invasive bladder cancer. Int J Radiat Oncol Biol Phys 56 (2003) 734-745
18. Pos F.J., van Tienhoven G., Hulshof M.C., et al. Concomitant boost radiotherapy for muscle invasive bladder cancer. Radiother Oncol 68 (2003) 75-80
19. Shipley W.U., Bae K., Efstathiou J.A., et al. Late pelvic toxicity following bladder-sparing therapy in patients with invasive bladder cancer: Analysis of RTOG 89-03, 95-06, 97-06, 99-06. Proceedings of the American Society for Therapeutic Radiology and Oncology 49th Annual Meeting, Los Angeles, CA. Int J Radiat Oncol Biol Phys 69 (2007) S8
20. Quilty P.M., and Duncan W. Primary radical radiotherapy for T3 transitional cell cancer of the bladder: An analysis of survival and control. Int J Radiat Oncol Biol Phys 12 (1986) 853-860
21. Duncan W., Williams J.R., Kerr G.R., et al. An analysis of the radiation related morbidity observed in a randomized trial of neutron therapy for bladder cancer. Int J Radiat Oncol Biol Phys 12 (1986) 2085-2092
22. Yu W.S., Sagerman R.H., Chung C.T., et al. Bladder carcinoma: Experience with radical and preoperative radiotherapy in 421 patients. Cancer 56 (1985) 1293-1299
23. Corcoran M.O., Thomas D.M., Lim A., et al. Invasive bladder cancer treated by radical external radiotherapy. Br J Urol 57 (1985) 40-42
24. Marcial V.A., Amato D.A., Brady L.W., et al. Split-course radiotherapy of carcinoma of the urinary bladder stages C and D1: A Radiation Therapy Oncology Group study. Am J Clin Oncol 8 (1985) 185-199
25. Pointon R.S., Read G., and Greene D. A randomised comparison of photons and 15 MeV neutrons for the treatment of carcinoma of the bladder. Br J Radiol 58 (1985) 219-224
26. Goodman G.B., Hislop T.G., Elwood J.M., et al. Conservation of bladder function in patients with invasive bladder cancer treated by definitive irradiation and selective cystectomy. Int J Radiat Oncol Biol Phys 7 (1981) 569-573
27. Shipley W.U., Kaufman D.S., Zehr E., et al. Selective bladder preservation by combined modality protocol treatment: Long-term outcomes of 190 patients with invasive bladder cancer. Urology 60 (2002) 62-68
28. Quilty P.M., Duncan W., and Kerr G.R. Results of a randomised study to evaluate influence of dose on morbidity in radiotherapy for bladder cancer. Clin Radiol 36 (1985) 615-618
29. Zelefsky M.J., Aschkenasy E., Kelsen S., et al. Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 39 (1997) 327-333
30. Feng M., Hanlon A.L., Pisansky T.M., et al. Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. Int J Radiat Oncol Biol Phys 68 (2007) 1417-1423
31. Al-Mamgani A., van Putten W.L., Heemsbergen W.D., et al. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 71 (2008) 1028-1033
32. Zelefsky M.J., Levin E.J., Hunt M., et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 1124-1129
33. Logsdon M.D., and Eifel P.J. FIGO IIIB squamous cell carcinoma of the cervix: An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 43 (1999) 763-775
34. Fellner C., Potter R., Knocke T.H., et al. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. Radiother Oncol 58 (2001) 53-62
35. Pelloski C.E., Palmer M., Chronowski G.M., et al. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62 (2005) 131-137
36. Schoeppel S.L., LaVigne M.L., Martel M.K., et al. Three-dimensional treatment planning of intracavitary gynecologic implants: Analysis of ten cases and implications for dose specification. Int J Radiat Oncol Biol Phys 28 (1994) 277-283
37. Ling C.C., Schell M.C., Working K.R., et al. CT-assisted assessment of bladder and rectum dose in gynecological implants. Int J Radiat Oncol Biol Phys 13 (1987) 1577-1582
38. Measurements ICoRUa. ICRU report 38: Dose and volume specification for reporting intracavitary therapy in gynecology (1985), International Commission on Radiation Units and Measurements, Bethesda
39. Barillot I., Horiot J.C., Maingon P., et al. Maximum and mean bladder dose defined from ultrasonography: Comparison with the ICRU reference in gynaecological brachytherapy. Radiother Oncol 30 (1994) 231-238
40. Kirisits C., Potter R., Lang S., et al. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62 (2005) 901-911
41. Potter R., Haie-Meder C., Van Limbergen E., et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 78 (2006) 67-77
42. Georg P., Dimopoulos J., Kirisits C., et al. The predictive value of dose volume parameters in MRI based cervical cancer brachytherapy for late adverse side effects in rectum, sigmoid and bladder. Int J Radiat Oncol Biol Phys 66 (2006) S42
43. Viswanathan A.N., Racine M., and Cormack R. Final results of a prospective study of MR-based interstitial gynecologic brachytherapy. Brachytherapy 7 (2008) 148
44. Viswanathan A.N., Cormack R., Holloway C.L., et al. Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer. Int J Radiat Oncol Biol Phys 66 (2006) 91-99
45. Peeters S.T., Heemsbergen W.D., van Putten W.L., et al. Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 61 (2005) 1019-1034
46. Karlsdottir A., Muren L.P., Wentzel-Larsen T., et al. Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity. Int J Radiat Oncol Biol Phys 70 (2008) 1478-1486
47. Cahlon O., Zelefsky M.J., Shippy A., et al. Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: Toxicity and biochemical outcomes. Int J Radiat Oncol Biol Phys 71 (2008) 330-337
48. Schultheiss T.E., Lee W.R., Hunt M.A., et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 37 (1997) 3-11
49. Eifel P.J., Jhingran A., Bodurka D.C., et al. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol 20 (2002) 3651-3657
50. Chen G.D., Lin L.Y., Wang P.H., et al. Urinary tract dysfunction after radical hysterectomy for cervical cancer. Gynecol Oncol 85 (2002) 292-297
51. Axelsen S.M., Bek K.M., and Petersen L.K. Urodynamic and ultrasound characteristics of incontinence after radical hysterectomy. Neurourol Urodyn 26 (2007) 794-799
52. Green N., Treible D., and Wallack H. Prostate cancer: Post-irradiation incontinence. J Urol 144 2 Pt 1 (1990) 307-309
53. Levine L.A., and Richie J.P. Urological complications of cyclophosphamide. J Urol 141 (1989) 1063-1069
54. Eifel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of Radiation Therapy Oncology Group trial (RTOG) 90-01. J Clin Oncol 22 (2004) 872-880
55. Lindholt J., and Hansen P.T. Prostatic carcinoma: Complications of megavoltage radiation therapy. Br J Urol 58 (1986) 52-54
56. Vanuytsel L., Ang K.K., Vandenbussche L., et al. Radiotherapy in multiple fractions per day for prostatic carcinoma: Late complications. Int J Radiat Oncol Biol Phys 12 (1986) 1589-1595
57. Horwich A., Dearnaley D., Huddart R., et al. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer. Radiother Oncol 75 (2005) 34-43